MidCap Financial

Summary

In 2008 was created MidCap Financial, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Bethesda.

The usual cause for the fund is to invest in rounds with 2 partakers. Despite the MidCap Financial, startups are often financed by New Leaf Venture Partners, Wellington Partners, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Silicon Valley Bank, Oxford Finance LLC, WuXi NextCODE. In the next rounds fund is usually obtained by Foresite Capital, CRG L.P., WuXi NextCODE.

The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Intarcia Therapeutics, Spectranetics, DNAnexus

The fund is generally included in 2-6 deals every year. Comparing to the other companies, this MidCap Financial performs on 30 percentage points more the average number of lead investments. Speaking about the real fund results, this Corporate Investor is 21 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2014. Deals in the range of 50 - 100 millions dollars are the general things for fund.